# OnCo record anthracycline (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/anthracycline/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "anthracycline" ;
  schema:name "Anthracyclines (doxorubicin, epirubicin)"@en ;
  schema:alternateName "anthracyclines"@en, "anthracycline-based"@en, "anthracycline-free"@en, "anthracycline-containing"@en, "liposomal doxorubicin"@en, "AC-T"@en, "FEC"@en, "anthracycline cardiotoxicity"@en ;
  schema:description "A family of red chemotherapy drugs derived from a soil bacterium that damage cancer DNA. Cornerstones of breast cancer, lymphoma, leukaemia and sarcoma treatment, but they weaken the heart in a dose-dependent way, so there is a lifetime limit."@en ;
  schema:url <https://onco.cc/terms/anthracycline/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anthracycline> ;
  schema:citation <https://en.wikipedia.org/wiki/Anthracycline> ;
  onco:related <https://onco.cc/terms/cardiotoxicity/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/r-chop/>, <https://onco.cc/terms/seven-plus-three/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/cardio-oncology/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/> .